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Microtubule dynamics: taking aim 
at a moving target 
Antitumor drugs of the vinca alkaloid and taxane classes function by suppressing the 
dynamics of microtubules in spindles, blocking cell division at metaphase. The drugs 
bind to various sites on the tubulin dimer and at different positions within the 
microtubule, suggesting that there are many unexplored targets for the design 
of novel drugs of this type. 
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Microtubules are major structural components in cells. and orthophosphate (Pi) during polymerization. Loss of 
They are important in the development and maintenance phosphate is not immediate, however, so that after poly- 
of cell shape, in cell reproduction and division, and in cel- merization there is a ‘cap’ of tubulin subunits bound to 
lular movement (reviewed in [1,2]). Microtubules are either GTP or GDP plus Pi at the end of the microtubule; 
highly dynamic assemblies of heterodimers of (Y and p because the subunits in the cap have a higher affinity for 
tubulin, arranged parallel to a cylindrical axis to form each other than the tubulin-GDP subunits in the body of 
tubes of diameter 25 nm that may be several to many p,rn the microtubule, the presence of the cap encourages 
long (Fig. 1). Polymerization of microtubules occurs by a growth, while loss of the cap leads to shortening [l]. 
nucleation-elongation mechanism in which the forma- 
tion of a short microtubule ‘nucleus’ is followed by elon- The fact that hydrolysis of GTP is irreversible thus creates 
gation of the microtubule at its ends by the reversible, unusual non-equilibrium dynamics. One consequence of 
noncovalent addition of tubulin dimers. this is that microtubule ends can stochastically switch 
between growing and shortening states (Fig. 2) in cells 
Microtubules are not simple equilibrium polymers. and in vitro; this is called dynamic instability [3].The two 
Tubulin dimers bind guanosine triphosphate (GTP) ends of the microtubule are not equivalent; one end, 
reversibly at a site in the p subunit and the GTP called the plus end, is kinetically more dynamic than the 
becomes hydrolyzed to guanosine diphosphate (GDP) other (the minus end). Although both ends can either 
(+) end 
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Fig. 1. Polymerization of microtubules. 
Heterodimers of 01 and p tubulin aggre- 
gate to form a short microtubule 
nucleus. Nucleation is followed by 
elongation of the microtubule at both 
ends by the reversible, noncovalent 
addition of tubulin dimers. Both ends 
can also shorten. The plus (+) end of 
the microtubule is kinetically more 
dynamic than the opposite or minus (-) 
end, growing and shortening over a 
wider range than the (-) end. 
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Fig. 2. Vinblastine suppresses the 
dynamic instability of microtubules. (a) 
Schematic showing how dynamic insta- 
bility is observed. The dark-shaded 
section of the microtubule is marked 
(for example by fluorescence) or fixed, 
and the distance from this fixed point to 
the two ends of the microtubule is mea- 
sured at different times. Both ends show 
stochastic switching between shortening 
and growing phases, with a wider 
dynamic range being shown by the (+) 
end. (b) Suppression of dynamic insta- 
bility length changes of individual 
microtubules by vinblastine, measured 
by video microscopy. Left, three control 
microtubules; right, two microtubules in 
the presence of 0.5 PM vinblastine. 
grow or shorten, the change in length at the plus end is 
much larger than the change in length at the minus end. 
Net growing of microtubules in a population in vitro or in 
cells can occur at plus ends and net shortening can occur 
at minus ends; when both of these occur at once, the 
microtubule is said to be treadmilling [4]. 
Dynamic instability is responsible for many microtubule- 
dependent processes in cells, the most dramatic of which 
is mitosis. Mitosis is the process during cell reproduction 
in which the replicated genetic material in the form of 
chromosomes is partitioned equally between two new 
‘daughter’ cells. When cells enter mitosis, the cytoskeletal 
microtubule network is dismantled and a bipolar spindle- 
shaped array of microtubules is assembled outwards from 
the centrosome. Microtubules from the spindle become 
attached to the chromosomes and move them to the two 
spindle poles (Fig. 3). Microtubule growing and shorten- 
ing dynamics are relatively slow in interphase cells. When 
cells enter mitosis, however, the rate of growing and 
shortening increases 20 to loo-fold so that spindle 
microtubules exchange their tubulin with tubulin in the 
soluble pool with half-times of -10 s (see [l]). These 
extremely rapid dynamics, which are highly sensitive to 
Metaphase of mitosis Anaphase of mitosis 
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Fig. 3. Partitioning of chromosomes to 
two daughter cells in mitosis. At meta- 
phase, the chromosomes have been 
transported to an equatorial position on 
the mitotic spindle by dynamic micro- 
tubules. At anaphase, microtubule 
dynamics change and the chromosomes 
partition and move to the two spindle 
poles on dynamic spindle microtubules. 
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modulation by antimitotic drugs, appear to be crucial in 
the intricate movements of the chromosomes. 
Antimitotic drugs 
A large number of chemically diverse substances, many of 
whiclh are derived from natural products, bind to tubulin 
or microtubules and inhibit cell proliferation by acting 
on spindle microtubules [1,2]. Most such drugs inhibit 
microtubule polymerization at high drug concentrations; 
these include colchicine (Fig. 4a) from the plant 
Colchicum autumnale and the antitumor drugs vinblastine 
(Fig. 4b) and vincristine from the plant Cathavanthus 
roseus. Other diverse compounds with similar actions 
include maytansine, rhizoxin, phomopsin, dolastatin and 
its derivatives [5,6], the cryptophycins [7], benzimidazole 
compounds such as nocodazole (see [1,2]), and the 
curacins [8]. At appropriately high concentrations, these 
drugs inhibit the polymerization of spindle microtubules 
or depolymerize existing spindle microtubules.They have 
therefore been thought to inhibit cell proliferation at 
mitosis by destroying the spindle microtubules required 
for mitosis [1,2]. More recently, the important new anti- 
tumor drug taxol (Fig. 4c) was isolated from the Pacific 
yew tree Taxus brev$dia (reviewed in [9]), which also 
inhibits cell replication by acting on microtubules. But 
taxol, in contrast to the other antimitotic drugs, can stim- 
ulate microtubule polymerization and stabilize micro- 
tubules.The remarkable success of taxol in the treatment 
of ovarian and breast cancer has stimulated an extensive 
search for new molecules that, like taxol, stimulate 
microtubule polymerization. 
Kinetic suppression of microtubule dynamics: a common 
mechanism of antimitotic effects 
A twist in the story came from our own recent demon- 
stration that, like taxol, vinblastine, colchicine, and other 
compounds that depolymerize microtubules can also sta- 
bilize microtubule dynamics at relatively low concentra- 
tions ([lo-121; reviewed in [13]). Although both 
colchicine and vinblastine were found some years ago to 
suppress the rate of microtubule disassembly caused by 
dilution (called ‘kinetic capping’, [13]), their stabilizing 
effects on dynamics were only fully recognized with the 
introduction of real-time differential-interference con- 
trast video microscopy. This technique allowed direct 
visualization of the stabilizing action of the drugs on the 
growing and shortening dynamics of individual micro- 
tubules (Fig. 2b) with high resolution. For example, vin- 
blastine (0.5-l FM) added to bovine brain microtubules 
at steady state greatly decreases the rate and extent of 
both growing and shortening at microtubule plus ends, 
and increases the fraction of time that the microtubules 
spend in an attenuated (or pause) state, in which they 
neither grow nor shorten detectably ([lo]; see Fig 2b). 
Vinblastine binds to microtubule ends with relatively 
high affinity (Fig. 5a) and the powerful suppressive action 
of the drug on microtubule dynamics appears to be due 
to the presence of a very small number (one or two) of 
vinblastine molecules at the ends of the microtubule 
(reviewed in [3]). 
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Fig. 4. Drugs that affect microtubule dynamics have diverse struc- 
tures. Structures are shown for (a) colchicine, (b) vinblastine, and 
(c) taxol. 
One of the more surprising results that emerged from 
these in vitro studies was the finding that, at low concen- 
trations, the drug suppresses dynamics without apprecia- 
bly depolymerizing microtubules. A qualitatively similar 
effect has recently been observed in living cells [14]. 
Colchicine also stabilizes microtubule ends but by a dif- 
ferent molecular mechanism from that of vinblastine. 
Unlike vinblastine, colchicine must first bind to 
soluble tubulin to act. Relatively small numbers of 
tubulin-colchicine complexes then become incorporated 
along with tubulin at the microtubule ends (Fig. 5b) [l 11. 
The incorporated tubulin-colchicine complexes again 
show profound effects on the rate and extent of growing 
and shortening, and powerfully increase the percentage of 
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Fig. 5. Antimitotic drugs interact with 
microtubules at diverse sites. (a) A few 
(one or two) molecules of vinblastine 
bound to high-affinity sites at the 
microtubule end are sufficient to affect 
microtubule dynamics. (b) Complexes 
of colchicine with tubulin monomers 
are incorporated into the microtubule 
instead of the normal P.--P tubulin 
dimers. (c) Taxol binds along the 
surface of the microtubule. 
time that the microtubules spend in the attenuated state. 
Like vinblastine, low concentrations of tub&n-colchicine 
complex also kinetically stabilize microtubules without 
causing appreciable depolymerization. 
Vinblastine and colchicine have similar effects to taxol 
The effects of the vinca alkaloids and colchicine on 
microtubule dynamics are much more similar to those of 
taxol than previously recognized.Taxol stimulates micro- 
tubule polymerization by binding directly to tubulin 
along the length of the microtubule (Fig. 5c) (see [9, 
1 l-13,15]). There is a taxol-binding site on each mole- 
cule of tubulin in microtubules, and the ability of taxol to 
increase microtubule polymerization is associated with 
nearly stoichiometric binding of taxol to tubulin in 
microtubules [15]. Binding of a small number of taxol 
molecules to microtubules stabilizes the microtubules 
[ 121. At relatively low ratios of bound taxol to tubulin in 
microtubules (e.g., 1 molecule of taxol per -200-600 
molecules of tubulin in microtubules) taxol inhibits the 
rate and extent of shortening, an action similar to that of 
colchicine and vinblastine. Like vinblastine and colchicine 
at low concentration, tax01 at very low concentrations 
kinetically suppresses microtubule dynamics without 
significantly changing the polymer mass [12]. 
Microtubule dynamics can also be suppressed by cellular 
proteins, the microtubule-associated proteins (MAPS), both 
in virro and in viva [1,2]. Among the best studied stabilizing 
MAPS are the neuronal proteins MAP2 and tau, which 
stabilize the microtubules in neuronal processes [ 1,16,17]. 
Interestingly tau suppresses steady-state dynamic instability 
in vitro in a manner that is qualitatively indistinguishable 
from taxol [18], consistent with the idea that antimitotic 
drugs mimic the actions of natural regulatory substances. 
Tau and MAP2 have common microtubule-binding 
domains consisting of three or four imperfect repeats of 18 
amino acids [16,17]. A synthetic 18 amino acid peptide 
representing the first binding repeat of bovine brain tau, 
and an 8 amino acid peptide representing the region 
between the first and second repeats, both bind weakly to 
microtubules in vitro (see [19], for example) and stabilize 
microtubule dynamics in a manner that is qualitatively 
indistinguishable from that of full-length tau [18]. These 
small peptides are thought to bind near the carboxy- 
terminus of tub&n, presumably to different regions, while 
taxol appears to bind near the amino-terminus of p (and 
perhaps CX) tubulin [20]. The effects of these peptides are 
qualitatively similar to that of taxol. 
Kinetic stabilization, inhibition of proliferation and cell death 
Given the above findings, the mechanism underlying the 
ability of antimitotic compounds to inhibit cell prolifera- 
tion and to kill tumor cells may be the kinetic stab- 
ilization of spindle microtubule dynamics, not the 
depolymerization or excessive polymerization of spindle 
microtubules. While investigating the antimitotic actions 
of vinblastine, taxol, and other antimitotic compounds in 
human tumor cells (HeLa), we discovered that at their 
lowest effective concentrations most of these compounds 
inhibit cell proliferation at mitosis; although the micro- 
tubule and chromosome organization of the spindles is 
only subtly altered and the microtubule polymer mass is 
similar to that in control cells [13, 21-231. Because low 
concentrations of these drugs kinetically stabilize micro- 
tubule dynamics without significantly changing the 
microtubule mass in vi&o and in cells, it is reasonable to 
suppose that the drugs also block spindle function by 
kinetically stabilizing the microtubules. 
As indicated previously, microtubule growing and shorten- 
ing dynamics increase dramatically when cells progress 
from interphase into mitosis, and it is probable that these 
rapid dynamics are critical for mitosis. It is remarkable that 
cells can construct a normal or nearly normal bipolar 
spindle in the presence of antimitotic drugs; therefore 
assembly of the spindle is not as critically dependent upon 
the dynamics of its microtubules as is spindle function 
after it is constructed. HeLa cells are blocked by these 
drugs at the metaphase-anaphase transition of mitosis (Fig. 
3); thus, it appears that rapid microtubule dynamics are 
especially important at metaphase. The transition from 
metaphase to anaphase is an important checkpoint in the 
cell cycle [24,25], which prevents cells from progressing 
into anaphase until the spindle is fully assembled and the 
chromosomes are properly poised for separation. Drugs 
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that suppress spindle microtubule dynamics may exert 
their antiproliferative and cytotoxic effects at this cell- 
cycle checkpoint. In support of this notion, we recently 
showed that prolonged blockage of HeLa cells at 
metaphase by low concentrations of vinblastine or taxol 
triggers apoptosis, a form of programmed cell death [26]. 
Lessons for the development of antimitotic antitumor drugs 
The emerging awareness that the dynamic properties of 
the microtubules in the spindle are critically important in 
cell proliferation and mitosis, and that suppressing spindle 
microtubule dynamics may be sufficient to induce cell 
death, is crucial for the design of novel drugs of this class. 
Furthermore, the response of a particular tumor cell to 
suppression of spindle microtubule dynamics appears to be 
the factor that determines whether that tumor cell will 
live or die.As two of the most successful antimitotic anti- 
tumor drug classes discovered thus far (the vinca alkaloids 
and taxanes) may exert their antitumor actions by sup- 
pressing microtubule dynamics, it seems clear that the syn- 
thesis and/or identification of compounds that suppress 
microtubule dynamics is a potentially fruitful avenue for 
future drug development. An understanding of what 
determines the response of a tumor cell to treatments of 
this kind might also, eventually, lead to expansion of the 
usefulness of these compounds.The antitumor specificities 
of the vinca alkaloids and taxanes are strikingly different; 
this might be due to differences in their pharmacokinetics, 
or to other differences that are not yet understood. Other 
compounds that act by stabilizing spindle microtubule 
dynamics might have entirely new tumor specificities. 
Finally, it is worth noting that microtubule dynamics can 
be suppressed by the interaction of diverse drugs, MAPS, 
and small peptides with tubulin at a large number of dif- 
ferent sites. Given the importance of microtubule 
dynamics in mitosis, it is plausible that cells have available 
a sophisticated array of molecules and mechanisms to 
regulate microtubule dynamics. Understanding these 
mechanisms may lead to development of yet more new 
drugs. Because only a few molecules are necessary for 
the effect, it might be possible to find drugs of very high 
potency with selectivity for diseased cells. Cancer is not 
the only target; diseases such as schistosomiasis and 
malaria are caused by parasites whose microtubule 
dynamics may be controlled in ways distinct from those 
in human cells. The possibilities for collaboration 
between chemists and biologists in these areas are many 
and varied, and the potential for progress is tremendous. 
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